Fruit mix is one of many medicines being researched to treat cancers.
A team at University of Sydney’s School of Pharmacy and Pharmaceutical Sciences has found it could be used to treat some types of cancers.
Dr David Williams says fruit mixes can be taken as a supplement and also injected directly into the bloodstream.
“The aim is to take it from a blood sample, inject it into the patient and then get it back into the blood, where it is then injected back into them,” he said.
“We’re working on a drug that’s specifically targeted to certain cancers.”
The idea is that when you inject it in there’s a chance that there is a little bit of that extra DNA that is going to be transferred from one cancer cell to the next.
“The team from the school’s Pharmacy Department is developing a drug called C-vitrolactone.
Dr Williams says it could help treat the disease-causing DNA in cancer cells.”
Dr Williams says that there are currently a few drugs that work well in the body and are safe for a short time, but they aren’t effective for a long time. “
It’s not a new molecule that’s been discovered in the last few years, so it’s exciting to think that the idea that it could potentially be used for a cancer that’s currently very aggressive, and one that’s difficult to treat.”
Dr Williams says that there are currently a few drugs that work well in the body and are safe for a short time, but they aren’t effective for a long time.
“When you have a long-term treatment, that’s when you need to look at what is working for the individual patient and the individual tumour,” he explained.
Dr Jonathan Gullis from the School of Biological Sciences said the drug would be very effective in treating patients with advanced or very aggressive cancers.
“Our patients are in a very early stage of the disease and we’ve got some pretty aggressive tumours, so the drug that we’re currently developing is targeting those cells very early in the disease,” he says.
Dr Gulles said the team was looking at using fruit mix as a treatment for cancer in children and adults.
He said it was the most promising cancer treatment to date.
“What we’ve found is that it’s really effective in children, so if we can get this drug into children, then we could potentially treat all of those cancers that are in children,” he added.
The research team said they were also working on creating a drug for cancer-related genetic diseases.
“One of the main goals of the study was to find out if there was an effective and safe treatment for these disease-related cancers, so that we could develop an effective drug to try to stop them progressing,” Dr Williams said.
“So we’re looking at whether or not we could target these cancers early in their progression and then give them an extra shot at stopping them from progressing,” he concluded.